Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study

被引：0
|
作者：
Fumery, M. [1 ]
Defrance, A. [2 ]
Roblin, X. [3 ]
Altwegg, R. [4 ]
Caron, B. [5 ]
Hebuterne, X. [6 ]
Carmen, S. [7 ]
Meyer, A. [8 ]
Nachury, M. [9 ]
Laharie, D. [10 ]
Nancey, S. [11 ]
Le Berre, C. [12 ]
Serrero, M. [13 ]
Geyl, S. [14 ]
Gilletta, C. [15 ]
Soune, P. Ah [16 ]
Duveau, N. [17 ]
Uzza, M. [18 ]
Abitbol, V. [19 ]
Biron, A. [20 ]
Minh, M. L. Tran [21 ]
Paupard, T. [22 ]
Vuitton, L. [23 ]
Elgharabawy, Y. [2 ]
Peyrin-Biroulet, L. [5 ]
机构：
[1] Amiens Univ Hosp, Gastroenterol, Amiens 1, France
[2] GETAID, Paris, France
[3] St Etienne Univ Hosp, Gastroenterol, St Etienne, France
[4] Montpellier Univ Hosp, Gastroenterol, Montpellier, France
[5] Nancy Univ Hosp, Gastroenterol, Nancy, France
[6] Nice Univ Hosp, Gastroenterol, Nice, France
[7] GH Ambroise Pare Hartmann, Gastroenterol, Neuilly, France
[8] Kremlin Bicetre, Gastroenterol, Paris, France
[9] Lille Univ Hosp, Gastroenterol, Lille, France
[10] Bordeaux Univ Hosp, Gastroenterol, Bordeaux, France
[11] Lyon Univ Hosp, Gastroenterol, Lyon, France
[12] Nantes Univ Hosp, Gastroenterol, Nantes, France
[13] Marseille Univ Hosp, Gastroenterol, Marseille, France
[14] Limoges Univ Hosp, Gastroenterol, Limoges, France
[15] Toulouse Univ Hosp, Gastroenterol, Toulouse, France
[16] Toulon Hosp, Gastroenterol, Toulon, France
[17] Roubaix Hosp, Gastroenterol, Roubaix, France
[18] Hop Mondor, Gastroenterol, Creteil, France
[19] Hop Cochin, Paris, France
[20] Reims Univ Hosp, Gastroenterol, Reims, France
[21] St Louis Hosp, Gastroenterol, Paris, France
[22] Dunkerque Hosp, Gastroenterol, Dunkerque, France
[23] Besancon Univ Hosp, Gastroenterol, Besancon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P638
引用
收藏
页码：770 / 770
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch
    Lan, Nan
    Shen, Bo
    [J]. ACG CASE REPORTS JOURNAL, 2024, 11 (09)
  • [22] Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study
    Oh, Kyunghwan
    Hong, Hee Seung
    Ham, Nam Seok
    Lee, Jungbok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Yoon, Hyuk
    Kim, You Sun
    Choi, Chang Hwan
    Ye, Byong Duk
    [J]. INTESTINAL RESEARCH, 2022, : 137 - 147
  • [23] Real-world effectiveness and safety of risankizumab in patients with moderate-to-severe multi-refractory Crohn's disease: a Belgian multi-centric cohort study
    Alsoud, D.
    Franchimont, D.
    D'Heygere, F.
    Bossuyt, P.
    Vijverman, A.
    Van Hootegem, P.
    Sabino, J.
    Cremer, A.
    Vermeire, S.
    Ferrante, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I516 - I517
  • [24] Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
    D'Haens, Geert
    Panaccione, Remo
    Baert, Filip
    Bossuyt, Peter
    Colombel, Jean-Frederic
    Danese, Silvio
    Dubinsky, Marla
    Feagan, Brian G.
    Hisamatsu, Tadakazu
    Lim, Allen
    Lindsay, James O.
    Loftus, Edward V., Jr.
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Ran, Zhihua
    Rubin, David T.
    Sandborn, William J.
    Schreiber, Stefan
    Neimark, Ezequiel
    Song, Alexandra
    Kligys, Kristina
    Pang, Yinuo
    Pivorunas, Valerie
    Berg, Sofie
    Duan, W. Rachel
    Huang, Bidan
    Kalabic, Jasmina
    Liao, Xiaomei
    Robinson, Anne
    Wallace, Kori
    Ferrante, Marc
    [J]. LANCET, 2022, 399 (10340): : 2015 - 2030
  • [25] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Nichols, Patrick
    Kozlicki, Miranda
    Fann, Jessica
    Zuckerman, Autumn
    Dalal, Robin
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S88 - S89
  • [26] Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
    Shitrit, A. Bar-Gil
    Siterman, M.
    Waterman, M.
    Hirsh, A.
    Khoury, T.
    Schwartz, D.
    Zittan, E.
    Adler, J.
    Koslowsky, B.
    Avni-Biron, I.
    Chowers, Y.
    Ron, Y.
    Israeli, E.
    Ungar, B.
    Yanai, H.
    Maharshak, N.
    Ben-Horin, S.
    Ben-Ya'acov, A.
    Eliakim, R.
    Dotan, I.
    Goldin, E.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S399 - S400
  • [27] EFFICACY OF RISANKIZUMAB RESCUE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND INADEQUATE RESPONSE TO RISANKIZUMAB MAINTENANCE THERAPY
    Baert, Filip J.
    Atreya, Raja
    Kakuta, Yoichi
    Long, Millie D.
    Roblin, Xavier
    Neimark, Ezequiel
    Song, Alexandra P.
    Wallace, Kori
    Kligys, Kristina
    Mallick, Madhuja
    Liao, Xiaomei
    Lim, Allen
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S967 - S967
  • [28] Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study
    Elford, A.
    Bishara, M.
    Plevris, N.
    Gros, B.
    Constantine-Cooke, N.
    Goodhand, J.
    Kennedy, N.
    Ahmad, T.
    Lees, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1523 - I1525
  • [29] Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study
    Elford, Alexander Thomas
    Bishara, Maria
    Plevris, Nikolas
    Gros, Beatriz
    Constantine-Cooke, Nathan
    Goodhand, James
    Kennedy, Nicholas A.
    Ahmad, Tariq
    Lees, Charlie W.
    [J]. FRONTLINE GASTROENTEROLOGY, 2024, 15 (04) : 297 - 304
  • [30] Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn's Disease and inadequate response to risankizumab maintenance therapy
    Baert, F. J.
    Atreya, R.
    Kakuta, Y.
    Long, M.
    Roblin, X.
    Neimark, E.
    Song, A.
    Wallace, K.
    Kingys, K.
    Mallick, M.
    Liao, X.
    Lim, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I128 - I128
12345